BioWorld

Aug. 22, 2002

Bypassing Bypassing, Marrow Stem Cells Invoke Angiogenesis To Relieve Clogged Leg Arteries

Other News To Note

Quarterly Earnings Reports

Increased Scrutiny Expected In Monitoring Phase IV Studies

WASHINGTON - When a drug company asks the FDA to clear a product for marketing, the parties often agree that the company will conduct a postmarketing, or Phase IV, study. (BioWorld Today) Read More

Focused On Tissue Repair, Collgard Names New CEO

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Mechanism underlying so-called idiopathic autism inception unveiled

BioWorld Science

Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...